MedPath

Perphenazine

Generic Name
Perphenazine
Drug Type
Small Molecule
Chemical Formula
C21H26ClN3OS
CAS Number
58-39-9
Unique Ingredient Identifier
FTA7XXY4EZ

Overview

An antipsychotic phenothiazine derivative with actions and uses similar to those of chlorpromazine.

Background

An antipsychotic phenothiazine derivative with actions and uses similar to those of chlorpromazine.

Indication

For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults.

Associated Conditions

  • Anxiety
  • Depression
  • Schizophrenia
  • Moderate Agitation
  • Moderate Anxiety
  • Moderate Depressed mood
  • Severe Anxiety
  • Severe Depressed mood
  • Severe Nausea and vomiting
  • Severe agitation

FDA Approved Products

Perphenazine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:8 mg in 1 1
Approved: 2021/04/06
NDC:63629-2253
Perphenazine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:8 mg in 1 1
Approved: 2022/09/16
NDC:72162-1164
Perphenazine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:2 mg in 1 1
Approved: 2022/09/16
NDC:72162-1162
Perphenazine
Manufacturer:American Health Packaging
Route:ORAL
Strength:4 mg in 1 1
Approved: 2022/10/04
NDC:68084-602
Perphenazine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:16 mg in 1 1
Approved: 2021/04/06
NDC:63629-2248

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath